Journal of psychiatric research
-
We performed an updated meta-analysis of noradrenalin reuptake inhibitor (NRI) augmentation therapy in patients with schizophrenia treated with antipsychotics based on a previous meta-analysis (Singh et al.). ⋯ NRIs may exert an effect on depressive symptoms, and seem to be well-tolerated treatments.